Page last updated: 2024-11-04

gatifloxacin and Pancreatitis

gatifloxacin has been researched along with Pancreatitis in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, O1
Chopra, K1
Yu, T1
Nalesnik, MA1
Amin, S1
Shakil, AO1

Other Studies

1 other study available for gatifloxacin and Pancreatitis

ArticleYear
Gatifloxacin-induced hepatotoxicity and acute pancreatitis.
    Annals of internal medicine, 2004, Jan-06, Volume: 140, Issue:1

    Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Female; Fluoroquinolones; Gatifloxacin

2004